Study Links Dust at Ground Zero to Prostate Cancer

Eighteen years after the September 11 attacks, Mount Sinai Health System researchers have found a higher incidence of prostate cancer among the World Trade Center (WTC) first responders than other populations, suggesting that chronic inflammation can facilitate the development of prostate cancer.

Emanuela Taioli, MD, PhD; and William Oh, MD

The most recent findings, published in June in Molecular Cancer Research, were led by Emanuela Taioli, MD, PhD, Director of the Institute for Translational Epidemiology and Associate Director for Population Science at The Tisch Cancer Institute; and William Oh, MD, Chief of the Division of Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai, and Deputy Director of The Tisch Cancer Institute.

“Our research supports the first line of evidence that acute World Trade Center dust exposure through inhalation can profoundly disturb gene expression and immune cell infiltration in the prostate,” says Dr. Taioli.

While working at Ground Zero, the first responders did not wear protective gear and were exposed to dust particles composed of volatile organic compounds from jet fuel, as well as asbestos, benzene, silica, glass fibers, polychlorinated biphenyls, polychlorinated dibenzofurans, and dioxins from the collapsed buildings. Given the fine particulate nature of the WTC dust, the researchers hypothesize that the toxins entered the blood through the lungs and eventually reached the prostate and other distal organs.

“The results of this study support our hypothesis that exposure to the dust at the World Trade Center caused chronic changes in the body,” says Dr. Oh. “The long-lasting inflammatory effect in the prostate revealed in our study calls for further investigation as to the effect of this exposure in other organs, such as the kidney or thyroid, or the central nervous system.”

In 2018, Dr. Taioli led a study published in the European Journal of Cancer Prevention, which reported that responders who spent more time working at Ground Zero and had a higher exposure to the dust cloud that formed after the WTC buildings collapsed, had more advanced stages of prostate cancer—stages III and IV—representing tumor invasion. Interestingly, the 2018 study found that at the beginning of their service at the WTC, the responders were mostly nonsmokers of diverse ethnic backgrounds who were considerably healthier than the general population and at lower risk for cancer.

According to the recent 2019 report, approximately 20 percent of human cancers are thought to be caused by chronic infection or inflammatory states, and chronically unresolved inflammation is related to increased risk of malignant disease. When tested in the laboratory, the toxic dust was shown to induce the secretion of cytokines— small proteins involved in modulating responses to inflammation infection, cancer, and trauma.

Mount Sinai runs the largest World Trade Center Health Program Clinical Center of Excellence in the New York metropolitan region, with 25,000 patients who have consented to participate in research. A biobank of more than 600 cancer samples from first responders has helped lay the groundwork for Mount Sinai’s WTC research findings.

Dr. Taioli says the latest research raises additional questions about whether air pollution, in general, causes an inflammatory response in people. “This work has larger implications for the population exposed to environmental particulates, such as emissions from motor vehicles, industrial processes, power generation, and the household combustion of solid fuel,” she says. “Inflammation could be the common pathway driving an increase in cancer occurrence.”

Push-Up Challenge Brings Awareness to Prostate Health

More than 120 Mount Sinai Health System faculty and staff completed more than 6,000 push-ups at the recent fourth annual Push-Up for Prostate Cancer Challenge held in Guggenheim Pavilion. The event, which commemorated Prostate Cancer Awareness Month in September, challenged each individual to complete 29 pushups in honor of the 29,000 men who die from prostate cancer in the United States each year.

“This very important event reflects Mount Sinai’s commitment to prostate cancer,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, who kicked off the challenge by completing 96 push-ups.

Dr. Tewari, left, and Dr. Charney, far right, with winner John Mendez.

Dr. Tewari, left, and Dr. Charney, far right, with winner Daphne Semet, MBA.

Dr. Tewari, left, and Dr. Charney, far right, with The Mount Sinai Hospital Urology team.

The first-place team trophy was awarded to the Department of Urology at The Mount Sinai Hospital, which completed 775 push-ups. Individual awards were given to the top male and female, as well as to the individual who completed the most modified push-ups. First place honors were given to John Mendez, Customer Service Representative, Department of Plastic and Reconstructive Surgery (male, 101 pushups); Daphne Semet, MBA, Vice Chair of Administration and Finance, Department of Pathology, Molecular and Cell-Based Medicine (female, 102 push-ups); and Mena Singh, MPA, Senior Accountant, Department of Finance (modified-style, 106 push-ups).

Push-Up Challenge Brings Awareness to Prostate Health The program also offered information about prostate cancer and provided cancer screenings and risk consultations. “Prostate cancer is one of the most common cancers, but it does not produce any symptoms, and the only way you can go after it is by being proactive,” said Ash Tewari, MBBS, MCh, the Kyung Hyun Kim, MD Chair in Urology, Mount Sinai Health System, who led the event.

September Is Prostate Cancer Awareness Month

Guest post by Ash Tewari, MBBS, MCh, the Kyung Hyun Kim MD, Chair in Urology in the Milton and Carroll Petrie Department of Urology at the Mount Sinai Health System

September is often a bittersweet moment in time: an end to weekends at the beach, late sunsets, grilling dinner in the backyard, and family vacations. But September also ushers in a new season: a return to school for our children, the start of a theater subscription, baseball playoffs, and more. For health professionals in the urology field, it is a special time. Prostate Cancer Awareness Month reminds us of how many men we can save with increased awareness and early detection and is a solemn reminder of those patients whose cancer had progressed too far to intervene successfully. (more…)

Is a PSA test still the most effective way to detect prostate cancer?

Guest post featuring Ronald D. Ennis, MD, Director Radiation Oncology at Mount Sinai St. Luke’s and Mount Sinai Roosevelt

Yes. The PSA or prostate-specific antigen blood test, although not perfect, is the most effective way to detect prostate cancer. It is the only available screening test for prostate cancer, and thus, is the only indicator to determine if a biopsy should be done. “We save people from dying of prostate cancer thanks to the PSA test, and there is no other way to do that right now,” explains Dr. Ronald D. Ennis. PSA is a protein made in the prostate gland. A PSA level that increases over time can indicate the presence of cancer. (more…)

Monitor Your Prostate Health as You Age

Guest post featuring Franklin C. Lowe, MD, MPH , Associate Director, Department of Urology, Mount Sinai St. Luke’s and Mount Sinai Roosevelt 

There are changes and challenges that come with getting older. Some may be hard to detect but can affect your quality of life. As men move through middle age, it becomes more likely their prostates will grow and could cause problems related to urination. According to Dr. Franklin C. Lowe , a urologist and the Associate Director of the Department of Urology at St. Luke’s and Roosevelt Hospitals, prostate-related problems can range from annoying to debilitating. (more…)

Robotic Surgery: An alternative to prostate cancer surveillance

Guest post featuring Caner Z. Dinlec, MD Physician-in-Charge, Division of Endourology and Stone Disease at Mount Sinai Beth Israel

Howard has always taken great care of himself. The 60-year-old is active, doesn’t smoke, eats a healthy diet and is diligent about seeing his doctor for annual wellness exams — through which his PSA (prostate-specific antigen) levels have been tested for years. About five years ago, Howard’s PSA levels started increasing. It wasn’t long before Howard’s PSA levels exceeded the 4 mg/mL mark, which is when levels are considered abnormal or high. (more…)

Pin It on Pinterest